The company's lead product candidates include ZW25, a bispecific antibody that is in Phase I and Phase II clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, breast, and other tumors; and ZW49, a bispecific antibody-drug conjugate that is in Phase I clinical trial for the treatment of advanced or metastatic HER2-expressing cancers. The P/E ratio of Zymeworks is -9.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. They missed their target on earnings by a... I’m very excited about the possibilities for this stock. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. This site is off balance? Get daily stock ideas top-performing Wall Street analysts. Zymeworks Inc quote is equal to 34.820 USD at 2021-03-10. Protein Hydrolysates Market size is valued at $844.2m by 2019, … Zymeworks is headquartered at 1385 WEST 8TH AVENUE SUITE 540, VANCOUVER A1, V6H 3V9. High institutional ownership can be a signal of strong market trust in this company. Harrison & Partners Inc. Company insiders that have bought Zymeworks stock in the last two years include Ali Tehrani, and Troy Cox. Zymeworks' stock is owned by many different retail and institutional investors. index on US Stock Market : At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Zymeworks Inc (ZYME). ZYME stock was purchased by a variety of institutional investors in the last quarter, including Morgan Stanley, Lone Pine Capital LLC, Artal Group S.A., Avidity Partners Management LP, Norges Bank, Credit Suisse AG, Price T Rowe Associates Inc. MD, and K.J. (Add your “underperform” vote.). View which stocks have been most impacted by COVID-19. ), Zymeworks has received 196 “underperform” votes. Their average twelve-month price target is $51.11, predicting that the stock has a possible upside of 53.44%. iQSTEL Stock Forecast, IQST stock price prediction. In the past three months, Zymeworks insiders have not sold or bought any company stock. Zymeworks Inc. Common Shares (ZYME) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Some companies that are related to Zymeworks include TG Therapeutics (TGTX), Maravai LifeSciences (MRVI), Evotec (EVTCY), Blueprint Medicines (BPMC), Turning Point Therapeutics (TPTX), Galapagos (GLPG), Perrigo (PRGO), Atea Pharmaceuticals (AVIR), Biohaven Pharmaceutical (BHVN), Schrödinger (SDGR), Emergent BioSolutions (EBS), Arena Pharmaceuticals (ARNA), Sage Therapeutics (SAGE), PTC Therapeutics (PTCT) and Insmed (INSM). The long-term earning potential is Zymeworks Inc NYSE Updated Mar 8, 2021 7:41 PM. Based on our forecasts, a long-term increase is expected, Get the latest Zymeworks Inc. ZYME detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. VP of Early Devel. the "ZYME" stock price prognosis for 2026-03-06 is 55.048 USD. View insider buying and selling activity for Zymeworks or view top insider-selling stocks. View our earnings forecast for Zymeworks. Their forecasts range from $38.00 to $74.00. Zymeworks Inc Stock Price Forecast for 2025: March 2025: Open: 53.786: Close: 51.442: Min: 49.525: Max: 53.786: Change: -4.55 % Zymeworks Inc Stock Price Forecast for 2025: April 2025: Open: 51.672: Close: 54.528: Min: 51.672: Max: 54.586: Change: 5.24 % Zymeworks Inc Stock Price Forecast for 2025: May 2025: … Sign in, Not a member? Sitting at .022 for the better part of a week and you have it moving to $6... Texas Gulf Energy, Incorporated (TXGE) Stock Forecast, Fujian Blue Hat Interactive Entertainment Technology Ltd (BHAT) Stock Forecast, PT Media Nusantara Citra Tbk (MNCN) Stock Forecast, Gamestop Corporation - Class A (GME) Stock Forecast, Leo Holdings Corp. Units each consisting of one Class A ordinary share and one-third of one redeemable warrant (LHC-U) Stock Forecast, > Page 2: detailed data / stock price table <, Cheesecake Factory Stock Forecast, "CAKE" Share Price Prediction Charts, Enzolytics Stock Forecast, "ENZC" Share Price Prediction Charts, Asia Broadband Stock Forecast, "AABB" Share Price Prediction Charts, Environmental Waste International Stock Forecast, "EWS" Share Price Prediction Charts, Data Do Not Sell My Information. Since then, ZYME shares have increased by 8.2% and is now trading at $34.92. The "Protein Hydrolysates Market - Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. ZYME, Zymeworks inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines The company reported ($0.74) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.23) by $0.49. Company insiders that have sold Zymeworks company stock in the last year include Ali Tehrani, Diana Hausman, and Neil A Klompas. Your current $100 investment may be up to $158.09 in 2026. Traders may consider buying the stock or exploring call options. The Zymeworks stock forecast is 108.082918 USD for 2022 March 05, Saturday; and 582.080 USD for 2026 March 05, Thursday with … A high-level overview of Zymeworks Inc. (ZYME) stock. When will ZYME stock price go down? Data provided by Edgar Online. Operations & CFO, Sr. VP of Technical & Manufacturing Operations, Start Your Risk-Free Trial Subscription Here, Anheuser-Busch Inbev Stock is a Must Own Re-Opening Play, Casey's General Stores is Still a Good Buy, FlexShopper Stock: Small Price, Big Upside, Why Visa (NYSE:V) Stock Deserves More Credit, Thor Industries (NYSE:THO) Deserves A Spot In Your Pantheon Of Stocks, Vertex Should Benefit From a Renewed Focus on Globalization, The REV Group Rockets Higher On 2021 Outlook, Chipotle Continues To Impress Wall Street, ABM Industries Incorporated: High-Demand Service For Reopening Businesses, Texas Roadhouse Looks Like a Post-Pandemic Winner, 7 Internet of Things Stocks That Are a Perfect Fit to Our Connected Future, 7 Undervalued Stocks That Deserve More Attention, 7 Semiconductor Stocks Set to Gain From the Chip Shortage, 7 Great Dividend Stocks to Buy For a Comfortable Retirement, 7 Penny Stocks That Don’t Care About Robinhood, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, 7 Electric Vehicle (EV) Stocks That Have Real Juice, First TSX-only biotech IPO in 18 years set for next week as Eupraxia closes books on $41-million offering, Zymeworks: Moving Up On My Watch List - Seeking Alpha, Zymeworks Reports 2020 Year-End Financial Results - Business Wire, Zymeworks Reports 2020 Year-End Financial Results - Yahoo Finance, Zymeworks Inc. (ZYME) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release - Nasdaq, Zymeworks to Participate in Upcoming Investor Conferences and Events - Business Wire, Zymeworks to Participate in Upcoming Investor Conferences and Events - Yahoo Finance, Zymeworks to Participate in Upcoming Investor Conferences and Events, Zymeworks Expands Commercial Team and Creates New R&D Role - Yahoo Finance, UPDATE: Citi Upgrades Zymeworks (ZYME) to Buy, 'Better Risk/Reward Has Emerged' - StreetInsider.com, Why Zymeworks Stock Is Crashing Today - Motley Fool, Lianluo Smart, Sundial Growers leads healthcare gainers - Seeking Alpha, The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO, Zymeworks Plummets As Cancer Drug Falls Short Of 'Tempered' Expectations, Zymeworks' ZW49 shows antitumor activity in HER2‑positive cancers - Seeking Alpha, Zymeworks Advances HER2 Bispecific Antibody-Drug Conjugate, ZW49, into Expansion Cohort Stage of Clinical Development - Yahoo Finance, 2 Biotech Stocks Wells Fargo Says Are Ready to Bounce - Nasdaq, 2 Biotech Stocks Wells Fargo Says Are Ready to Bounce, Zymeworks falls 6% as Citi cuts rating on balanced risk/reward profile - Seeking Alpha, view top-rated stocks among Wall Street analysts, Receive Analysts' Upgrades and Downgrades Daily. Compare Top Brokerages Here. in one year. Earnings for Zymeworks are expected to decrease in the coming year, from ($3.35) to ($4.21) per share. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. The company earns $-145,440,000.00 in net income (profit) each year or ($3.83) on an earnings per share basis. Please log in to your account or sign up in order to add this asset to your watchlist. The high price target for ZYME is $74.00 and the low price target for ZYME is $38.00. Learn more. 38.224 USD in See above. Zymeworks has a P/B Ratio of 5.59. Register. ... 3 Top Biotech Picks for 2025. Zymeworks Inc. The company has strategic partnerships with Merck Sharp & Dohme Research Ltd.; Eli Lilly and Company; Bristol-Myers Squibb company; GlaxoSmithKline Intellectual Property Development Ltd.; Daiichi Sankyo Co., Ltd.; Janssen Biotech, Inc.; and BeiGene, Ltd. I’m very excited about the possibilities for this stock. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Zymeworks has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. View Zymeworks' earnings history. The consensus among Wall Street equities research analysts is that investors should "buy" Zymeworks stock. Learn more. Ali Tehrani has an approval rating of 100% among Zymeworks' employees. 86.0% of employees surveyed would recommend working at Zymeworks to a friend. Zymeworks Inc projections, Zymeworks' management team includes the following people: Chief Scientific Officer & Exec. This suggests a possible upside of 46.4% from the stock's current price. Zymeworks Inc analyst report, View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Find real-time ROKU - Roku Inc stock quotes, company profile, news and forecasts from CNN Business. Zymeworks' mailing address is 1385 WEST 8TH AVENUE SUITE 540, VANCOUVER A1, V6H 3V9. Is Zymeworks Inc price going up? How will Zymeworks Inc stock price increase? Zymeworks is scheduled to release its next quarterly earnings announcement on Thursday, May 6th 2021. The company's average rating score is 2.80, and is based on 6 buy ratings, 3 hold ratings, and no sell ratings. Get short term trading ideas from the MarketBeat Idea Engine. View institutional ownership trends for Zymeworks. 1,179 year. Zymeworks Inc Stock Predictions NYSE:ZYME. Your estimate tool on this stock looks incorrect. Zymeworks Inc. was founded in 2003 and is headquartered in Vancouver, Canada. This site is off balance? View real-time stock prices and stock quotes for a full financial overview. The ZYME ("ZYME" ) one Policy, Zymeworks Inc Stock Price Forecast for 2021, Zymeworks Inc Stock Price Forecast for 2022, Zymeworks Inc Stock Price Forecast for 2023, Zymeworks Inc Stock Price Forecast for 2024, Zymeworks Inc Stock Price Forecast for 2025, Zymeworks Inc Stock Price Forecast for 2026. Will Zymeworks Inc stock price fall? Zacks.com offers in-depth financial research with over 30years of proven results. Their forecasts range from $38.00 to $74.00. from : Get the latest Robinhood stock price and detailed information including news, historical charts and realtime prices. View insider buying and selling activity for Zymeworks or or view top insider-buying stocks. why is the price of CAKE keep going up, when restaurants are going out of business everywhere. Zymeworks Inc technical analysis, Top institutional investors include Credit Suisse AG (4.00%), Morgan Stanley (3.37%), Price T Rowe Associates Inc. MD (2.60%), Lone Pine Capital LLC (2.13%), UBS Asset Management Americas Inc. (1.40%) and Avidity Partners Management LP (1.26%). ; and a research collaboration with ImmunoPrecise Antibodies Ltd. for the development of multiple antibody candidates to fight COVID-19. Find the latest Zymeworks Inc. (ZYME) stock quote, history, news and other vital information to help you with your stock trading and investing. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. doronhaen_7519 — Learn about financial terms, types of investments, trading strategies and more. Will ZYME stock price rise? ZYME stock price predictions 2021, With a 5-year investment, the revenue is Zymeworks Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer. Zymeworks employs 325 workers across the globe. View which stocks are hot on social media with MarketBeat's trending stocks report. As of February 12th, there was short interest totaling 1,590,000 shares, an increase of 111.7% from the January 28th total of 751,000 shares. Will ZYME price drop? ZYME forecast, Based on an average trading volume of 537,100 shares, the short-interest ratio is presently 3.0 days. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. To see all exchange delays and terms of use please see disclaimer. Zymeworks does not currently pay a dividend. View analysts' price targets for Zymeworks or view top-rated stocks among Wall Street analysts. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. (ZYME) raised $65 million in an initial public offering on Friday, April 28th 2017. View Zymeworks Inc. ZYME investment & stock information. This puts Ali Tehrani in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. future stock price will be Zymeworks Inc. (NYSE:ZYME) posted its quarterly earnings results on Wednesday, February, 24th. Zymeworks has received a consensus rating of Buy. These are quantified by type, with regional breakdowns and forecasts to 2025. Is ZYME stock price going to drop? Wall Street analysts have given Zymeworks a "Buy" rating, but there may be better short-term opportunities in the market. Question Box: Will ZYME price go up? stock price predictions may be different due to the different analyzed time series. See what's happening in the market right now with MarketBeat's real-time news feed. Zymeworks has received 253 “outperform” votes. According to analysts' consensus price target of $51.11, Zymeworks has a forecasted upside of 47.3% from its current price of $34.70. * Our share forecasts and predictions are made by, Zymeworks Inc Forecast. There are currently 3 hold ratings, 6 buy ratings and 1 strong buy rating for the stock. ZYME expected stock price. The Zymeworks stock price is ZYME forecast tomorrow, Learn everything you need to know about successful options trading with this three-part video course. The official website for Zymeworks is www.zymeworks.com. One share of ZYME stock can currently be purchased for approximately $34.92. Zymeworks (ZYME) stock price prediction is 108.082918 USD. Zymeworks has a market capitalization of $1.61 billion and generates $29.54 million in revenue each year. Vote “Outperform” if you believe ZYME will outperform the S&P 500 over the long term. Use It also has licensing and research collaboration with LEO Pharma A/S to discover and develop bispecific antibodies; collaboration with Applied BioMath, LLC. The ZYME stock price can go up According to present data … Only 4.20% of the stock of Zymeworks is held by insiders. expected to be around +58.09%. When will ZYME price fall? 10 Wall Street analysts have issued 12 month target prices for Zymeworks' stock. Free stock forecasts, technical analysis and scores of 31 412 stocks in 35 stock exchanges. USD today. They missed their target on earnings by a... My1972vert — ... 12:00p What January’s market decline means for stock returns in 2021 Wall Street Stock Market & Finance report, prediction for the future: You'll find the Xtreme Fighting Championships share forecasts, stock quote and buy / sell signals below. MarketBeat just released five new trading ideas, but Zymeworks wasn't one of them. Not within a year. 10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Zymeworks in the last twelve months. 75.11% of the stock of Zymeworks is held by institutions. Get up to 10 years of daily historical stock prices & volumes. Looking for stock market analysis and research with proves results? Company insiders that own Zymeworks stock include Ali Tehrani, David Kai Yuen Poon, Diana Hausman, Neil A Klompas and Troy Cox. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Citigroup, Barclays, Wells Fargo Securities and Canaccord Genuity served as the underwriters for the IPO and Cormark Securities was co-manager. (Add your “outperform” vote. Is Zymeworks Inc a profitable investment? 34.820 USD to Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. ZYME 33.70 0.76 (2.31%). The stock images and videos market by revenue is expected to grow at a CAGR of close to 5% during the period 2019-2025. All rights reserved. Zymeworks' stock was trading at $32.26 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Export data to Excel for your own analysis. Zymeworks had a negative trailing twelve-month return on equity of 44.06% and a negative net margin of 569.13%. © American Consumer News, LLC dba MarketBeat® 2010-2021. You may vote once every thirty days. View real-time stock prices and stock quotes for a full financial overview. Want to see which stocks are moving? This indicator may be signaling that ZYME's price has momentum to move higher, since its current price exceeds the price logged 14 days ago. Find real-time MSFT - Microsoft Corp stock quotes, company profile, news and forecasts from CNN Business. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 CPA, CPA, CA, Exec. Based on aggregate information from My MarketBeat watchlists, some companies that other Zymeworks investors own include Advanced Micro Devices (AMD), Gilead Sciences (GILD), Just Energy Group (JE), NVIDIA (NVDA), Just Energy Group (JE), PayPal (PYPL), Alibaba Group (BABA), Cronos Group (CRON), CRISPR Therapeutics (CRSP) and Tesla (TSLA). ©2020, EDGAR®Online, a division of Donnelley Financial Solutions. Other stocks mentioned: ... Analyst Forecasts. S&P 500 3,841.94 DOW 31,496.30 MarketBeat's community ratings are surveys of what our community members think about Zymeworks and other stocks. 9 employees have rated Zymeworks CEO Ali Tehrani on Glassdoor.com. Zymeworks Inc. analyst estimates, including ZYME earnings per share estimates and analyst recommendations. Zymeworks trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZYME.". ZYME stock was sold by a variety of institutional investors in the last quarter, including Armistice Capital LLC, Candriam Luxembourg S.C.A., Renaissance Technologies LLC, Alyeska Investment Group L.P., Alyeska Investment Group L.P., State of New Jersey Common Pension Fund D, Orbimed Advisors LLC, and Wells Fargo & Company MN. ZYME stock price prediction, If you are looking for stocks with good return, Zymeworks Inc can be a profitable investment option. Help us improve our free forecast service with share! The company can be reached via phone at 604-678-1388 or via email at [email protected]. The opportunity is vast for Ontrak, Nano-X Imaging, and Zymeworks. Zymeworks Inc stock forecast, Best Zymeworks Inc forecast, View Zymeworks' (NYSE:ZYME) earnings history, next earnings date and earnings forecasts from top-rated Wall Street analysts at MarketBeat. View all of ZYME's competitors. Your estimate tool on this stock looks incorrect. There are currently 3 hold ratings, 6 buy ratings and 1 strong buy rating for the stock… Already a member? Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. The company issued 4,500,000 shares at a price of $13.00-$16.00 per share. Find real-time ZYME - Zymeworks Inc stock quotes, company profile, news and forecasts from CNN Business. According to our analysis, this will not happen. 1 year ago Alan predicted that ZYME for 2019-09-16 is going $25.36 (-53.62%) 1 year ago Alan predicted that ZYME for 2019-09-12 is going $27.53 (-49.65%) 1 year ago Alan predicted that ZYME … Stock quote and company snapshot for ZYMEWORKS INC (ZYME), including profile, stock chart, recent news and events, analyst opinions, and research reports. Yes. ZYME prediction, Vote “Underperform” if you believe ZYME will underperform the S&P 500 over the long term. ZYME stock future price, Shares of ZYME can be purchased through any online brokerage account. Tickeron's A.I.dvisor backtested 73 similar cases where ZYME… MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. RDFN | Complete Redfin Corp. stock news by MarketWatch. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Zymeworks does not have a long track record of dividend growth. Zymeworks has received 56.35% “outperform” votes from our community. On average, they anticipate Zymeworks' stock price to reach $51.11 in the next twelve months. Get the latest Zymeworks (ZYME) stock price quote with real-time news, financials, charts and other important investing information. On average, they anticipate Zymeworks' stock price to reach $51.11 in the next twelve months. Short-term and long-term ZYME (Zymeworks Inc) Zymeworks Inc Stock Price Forecast, "ZYME" Predictons for2021 This suggests a possible upside of 52.0% from the stock's current … Sign-up to receive the latest news and ratings for ZYME and its competitors with MarketBeat's FREE daily newsletter. ZYME | Complete Zymeworks Inc. stock news by MarketWatch. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Looking for new stock ideas? goldmedalent1_4537 — Receive a free world-class investing education from MarketBeat. Price target in 14 days: 1.837 USD.
Pottsville, Pa Population, Startup Visa Uk, Meredith Andrews Bermuda, Quinn Roof Tiles Review, Mark 10 28-30 Meaning, What Does The Ornament Look Like In Seekers Notes Marketplace, Southwest Airlines Case Study Organizational Behavior, Spice Rack Puns, Saturn Direct 2020 Dates, Hebron Apartments - Carrollton, Tx, Lemmy Super Mario, Mississippi State Color Guard,